Poster SESSIONS
60
Poster, 24 June 2014
P-22-009
Short- and longer-term treatment with lur-
asidone in patients with bipolar I depression:
Effect on metabolic syndrome
Susan McElroy, Cincinnati, USA
A. Pikalov, J. Cucchiaro, J. Hsu, H. Kroger,
D. Phillips, A. Loebel
P-22-010
The effect of childhood abuse and neglect on
clinical severity in mood disorders
Giselle Kraus, Montreal, Canada
N. Lebaron, X. Zhang, A. Iskric, E. Yung,
J. Lober, N. Low
P-23
POSTER SESSION
17:15–18:45
Hall B
Depression B
P-23-001
Spatiotemporal activation during verbal flu-
ency task in remitted patients with major
depression: An MEG study
Kazuhiro Shishida, Hiroshima, Japan
N. Kanayama, A. Hashizume, H. Yamashita,
Y. Okamoto, K. Kurisu, S. Yamawaki
P-23-002
How often have depressed patients received
psychoeducation about antidepressants
treatment? The survey of 424 outpatients
in Japan
Kudo Shuhei, Hirosaki-Si, Aomori-Ken, Japan
Y.-F. Norio, S. Norio, S. Yasusi, F. Akira, T. Tetu,
I. Msamiti, T. Koji, N. Taku, N. Kazuhiko
P-23-003
Baseline difference between patients‘ and
clinicians‘ rated illness severity scores and
subsequent outcomes in major depressive
disorder: Analysis of the STAR*D Data
Mitsuhiro Tada, Tokyo, Japan
T. Suzuki, T. Abe, B. G. Pollock, M. Mimura,
H. Uchida
P-23-004
The evolution of antidepressant switch and
augmentation therapy in the treatment of
depression: A chart review
Ryousuke Tarumi, Hachiouji, Japan
H. Uchida, T. Suzuki, H. Tani, R. Den, N. Sawa-
da, A. Ohtani, H. Sakurai, C. Tsutsumi-Ozawa,
M. Mimura
P-23-005
The study of treatment response in depres-
sive patients with alcohol use disorders by
using HAM-D
Masaya Tayama, Sapporo, Japan
E. Hashimoto, T. Saito
P-23-006
The influence of 5-HTTLPR genotypes on
the association between paroxetine plasma
concentrations and their therapeutic effects
in patients with major depressive disorder
Tetsu Tomita, Hirosaki, Japan
N. Yasui-Furukori, T. Nakagami, S. Tsuchimine,
M. Ishioka, A. Kaneda, S. Kaneko
P-23-007
Decreased serum levels of polyunsaturated
fatty acids and folate, but not brain-derived
neurotrophic factor, in adolescent depression
Shoko Tsuchimine, Aomori, Japan
N. Yasui-Furukori, M. Saito, S. Kaneko
P-23-008
Antidepressant dose increase or stay in early
non-responders with depression
Fumihiko Ueno, Yokosuka, Japan
T. Suzuki, S. Nakajima, M. Mimura, H. Uchida
P-23-009
Leukocyte gene expression-based diagnostic
test for major depressive disorder: A pilot
and replication study
Shinya Watanabe, Tokushima, Japan
J.-I. Iga, S. Numata, S. Shimodera, H. Fujita,
K. Ishii, T. Ohmori
P-23-010
Effect of repeated restraint stress on gluco-
corticoid receptor function in the rat brain
Mitsuhiro Yoshioka, Sapporo, Japan
R. Ghebreab, T. Yoshida, T. Izumi, Y. Ohmura
P-23-011
Efficacy and safety of vilazodone 20 mg and
40 mg in major depressive disorder: A ran-
domized, double-blind, placebo- and active-
controlled trial
Carl Gommoll, Jersey City, USA
M. Mathews, D. Chen, R. Nunez, A. Khan
P-23-012
Agomelatine‘s efficacy in positive and nega-
tive affects in depression
Philip Gorwood, Paris, France
G. Vaiva, E. Corruble, P.-M. Llorca, F. J. Bayle,
M. D. Carmen Munoz Sanz, P. Courtet
